The MarketWatch News Department was not involved in the creation of this content. bioAffinity Technologies' noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to ...
AZmed, one of the leading companies in artificial intelligence (AI) for radiology, announced today the CE marking of AZnod, ...
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
CT scan findings indicating ILAs included reticular pathologies or ground-glass opacities (GGOs), traction-type bronchiectasis, lung architectural distortion, non-emphysematous lung cysts, and ...
Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show a small white spot in the center of your lungs—a pulmonary or lung ...
The good news is that imaging scans do detect lung cancer early. The bad news, according to a study in the current issue of the journal Radiology, is that they are much more likely to detect harmless ...
Lung cancer is the No. 1 cause of cancer-related death in the United States. Screening with low dose computed tomography (called low dose CT or LDCT) can save lives for people at high risk for this ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment SAN ANTONIO--(BUSINESS WIRE)-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results